Correlation of retinal vascular characteristics with laboratory and ocular findings in Fabry disease: exploring ocular diagnostic biomarkers

Table 3 FAZ and VAD in patients with and without cornea verticillata compared to controls

	FD eyes with cornea verticillata (n = 40–42); mean ± SD	FD eyes without cornea verticillata (n = 34); mean ± SD	Controls (n = 48); mean ± SD	p value
FAZ area (mm²)
Full thickness	0.22 ± 0.09	0.26 ± 0.11	0.25 ± 0.07	0.196
SVP	0.35 ± 0.11	0.38 ± 0.13^b	0.35 ± 0.08^b	0.780
ICP	0.19 ± 0.10	0.24 ± 0.11	0.24 ± 0.069	0.142
DCP	0.38 ± 0.10^a	0.41 ± 0.21	0.36 ± 0.07^a	0.677
VAD (%)
SVP	50.95 ± 8.74^a	47.41 ± 13.19^b	26.51 ± 6.18^ab	< 0.001
ICP	31.70 ± 6.63^ac	28.94 ± 7.62^bc	20.17 ± 4.38^ab	< 0.001
DCP	35.30 ± 6.99^ac	28.47 ± 9.44^bc	21.71 ± 5.08^ab	< 0.001

Kruskal Wallis Test, Bold indicates statistical significance (p < 0.05)
^ap < 0.01 using Mann–Whitney U Test between eyes with cornea verticillata and controls
^bp < 0.05 using Mann–Whitney U Test between eyes without cornea verticillata and controls
^cp < 0.01 using Mann–Whitney U Test between eyes with and without cornea verticillata

ISSN: 1750-1172